Johnson & Johnson ($JNJ) has opened the doors on its Takeda-partnered biotech incubator in Israel, enrolling its first class of startups and advancing its global plan to accelerate R&D through external innovation. The incubator, dubbed FutuRx, is one of J&J's 5 worldwide Innovation Centers, The Times of Israel reports, and its first two members, Hepy Biosciences and XoNovo, are already getting to work on early-stage drugs. News